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Transdermal Lidocaine for Perioperative Pain: a Systematic Review of the
Literature
Alexa Cohen, Jordan Smoker, Mohammad R. Rasouli, Eric S. Schwenk*

Introduction: Recent data have shown that the risk of taking chronic opioids after
surgery increases after about 5 days of postoperative opioid therapy. Alternatives to
opioids are desirable, and transdermal lidocaine is one such perioperative multimodal
agent. This review provides a summary of the perioperative studies that have examined
transdermal lidocaine as an analgesic in the perioperative period.
Methods: We conducted searches of PubMed and Scopus databases. Studies
involving patients who were undergoing surgery and were given either transdermal
lidocaine, placebo, or active comparator in the perioperative period with the primary
endpoint of improvement in pain were included in the analysis. Only randomized
controlled trails were included.
Results: Overall, five out of the seven studies reported lower pain ratings in the
lidocaine group compared to placebo. Three out of the four studies that used the mean
visual analog scale (VAS) as primary endpoint reported that transdermal lidocaine
decreased postoperative pain ratings at rest, which remained reduced for 6 h, 24, and
72 h. In four studies, there was no difference in opioid consumption between treatment
and placebo groups.

Discussion: This review demonstrates that transdermal lidocaine may provide a
modest improvement in pain ratings in the perioperative period, but the number of
studies was limited and the duration of benefit is limited. Although five out of seven
studies showed a decrease in pain ratings with transdermal lidocaine, this reduction
was typically only observed at rest and often did not translate to decreased opioid
consumption, making the overall clinical benefit questionable.

